BEN forms Skye Salud JV with KNOBLOCH to deploy sovereign AI healthcare platform in Mexico

Brand Engagement Network Inc.

Skye Salud JV: Skye Inteligencia LATAM and KNOBLOCH each 50% ownership; BEN receives 35% of applicable gross revenues from Skye Inteligencia LATAM ops including Skye Salud.
KNOBLOCH audits 99% of Mexico's private pharmaceutical market, tracking sell-out data from 82 institutions.
Pilot programs targeted for Q1 2026 across public hospitals, pharmacy clinics, and chronic-disease programs in Mexico.
Mexico's EHR/EMR market projected to grow from $2.4B (2025) to $5.3B by 2031 at ~14% CAGR.
Skye Salud aims to deploy Mexico's first nationwide sovereign augmented-intelligence platform serving 130M+ people.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.